FindTrial
Sign In

Data collection of the patients receiving Vivitra® (Observational i.e. Non interventional)

A Retrospective Safety Data Collection Registry of VivitraTM (Trastuzumab) - VivitraTM Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/05/013754
Enrollment
150
Registered
2018-05-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- 1. Metastatic breast cancer 2. Metastatic Gastric Cancer 3. Early Breast Cancer

Interventions

None listed

Sponsors

Cadila Healthcare Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient should have completed the 4 cycle of VivitraTM treatment on the approved indications

Exclusion criteria

Exclusion criteria: Any reason which may prevent the doctor to enroll the patient in the registry.

Design outcomes

Primary

MeasureTime frame
1 Current status of the patients 2 Patient/Doctor assessment of therapy 3 Patient compliance 4 Quality of lifeTimepoint: After 18 Months from the study start—

Secondary

MeasureTime frame
NATimepoint: NA—

Countries

India

Contacts

Public ContactDr Amit Bhalla

Zydus Cadila

amitbhalla@zyduscadila.com8128668357

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026